169 related articles for article (PubMed ID: 11137795)
1. Dosimetry from organ to cellular dimensions.
Thierens HM; Monsieurs MA; Brans B; Van Driessche T; Christiaens I; Dierckx RA
Comput Med Imaging Graph; 2001; 25(2):187-93. PubMed ID: 11137795
[TBL] [Abstract][Full Text] [Related]
2. Absorbed doses for internal radiotherapy from 22 beta-emitting radionuclides: beta dosimetry of small spheres.
Bardiès M; Chatal JF
Phys Med Biol; 1994 Jun; 39(6):961-81. PubMed ID: 15551573
[TBL] [Abstract][Full Text] [Related]
3. DOSIS: An integrated computational tool for patient-specific dosimetry in nuclear medicine by Monte Carlo and dose point kernel approaches.
Pérez P; Valente M
Appl Radiat Isot; 2019 Aug; 150():135-140. PubMed ID: 31146217
[TBL] [Abstract][Full Text] [Related]
4. A dose point kernel database using GATE Monte Carlo simulation toolkit for nuclear medicine applications: comparison with other Monte Carlo codes.
Papadimitroulas P; Loudos G; Nikiforidis GC; Kagadis GC
Med Phys; 2012 Aug; 39(8):5238-47. PubMed ID: 22894448
[TBL] [Abstract][Full Text] [Related]
5. Dosimetric characterization of radionuclides for systemic tumor therapy: influence of particle range, photon emission, and subcellular distribution.
Uusijärvi H; Bernhardt P; Ericsson T; Forssell-Aronsson E
Med Phys; 2006 Sep; 33(9):3260-9. PubMed ID: 17022220
[TBL] [Abstract][Full Text] [Related]
6. Monte Carlo dosimetry of a realistic multicellular model of follicular lymphoma in a context of radioimmunotherapy.
Bordes J; Incerti S; Mora-Ramirez E; Tranel J; Rossi C; Bezombes C; Bordenave J; Bardiès M; Brown R; Bordage MC
Med Phys; 2020 Oct; 47(10):5222-5234. PubMed ID: 32623743
[TBL] [Abstract][Full Text] [Related]
7. Validation of the EGS usercode DOSE3D for internal beta dose calculation at the cellular and tissue levels.
Coulot J; Ricard M; Aubert B
Phys Med Biol; 2003 Aug; 48(16):2591-602. PubMed ID: 12974576
[TBL] [Abstract][Full Text] [Related]
8. Monte Carlo dose voxel kernel calculations of beta-emitting and Auger-emitting radionuclides for internal dosimetry: A comparison between EGSnrcMP and EGS4.
Strigari L; Menghi E; D'Andrea M; Benassi M
Med Phys; 2006 Sep; 33(9):3383-9. PubMed ID: 17022234
[TBL] [Abstract][Full Text] [Related]
9. 131I-tositumomab radioimmunotherapy: initial tumor dose-response results using 3-dimensional dosimetry including radiobiologic modeling.
Dewaraja YK; Schipper MJ; Roberson PL; Wilderman SJ; Amro H; Regan DD; Koral KF; Kaminski MS; Avram AM
J Nucl Med; 2010 Jul; 51(7):1155-62. PubMed ID: 20554734
[TBL] [Abstract][Full Text] [Related]
10. Implementation and evaluation of patient-specific three-dimensional internal dosimetry.
Kolbert KS; Sgouros G; Scott AM; Bronstein JE; Malane RA; Zhang J; Kalaigian H; McNamara S; Schwartz L; Larson SM
J Nucl Med; 1997 Feb; 38(2):301-8. PubMed ID: 9025759
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow dosimetry using blood-based models for radiolabeled antibody therapy: a multiinstitutional comparison.
Wessels BW; Bolch WE; Bouchet LG; Breitz HB; Denardo GL; Meredith RF; Stabin MG; Sgouros G;
J Nucl Med; 2004 Oct; 45(10):1725-33. PubMed ID: 15471841
[TBL] [Abstract][Full Text] [Related]
12. Studies on the red marrow dosimetry in radioimmunotherapy: an experimental investigation of factors influencing the radiation-induced myelotoxicity in therapy with beta-, Auger/conversion electron-, or alpha-emitters.
Behr TM; Sgouros G; Stabin MG; Béhé M; Angerstein C; Blumenthal RD; Apostolidis C; Molinet R; Sharkey RM; Koch L; Goldenberg DM; Becker W
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3031s-3043s. PubMed ID: 10541340
[TBL] [Abstract][Full Text] [Related]
13. Effect of microdistribution of alpha and beta-emitters in targeted radionuclide therapies on delivered absorbed dose in a GATE model of bone marrow.
Tranel J; Feng FY; James SS; Hope TA
Phys Med Biol; 2021 Jan; 66(3):035016. PubMed ID: 33321484
[TBL] [Abstract][Full Text] [Related]
14. High-dose (131)I-tositumomab (anti-CD20) radioimmunotherapy for non-Hodgkin's lymphoma: adjusting radiation absorbed dose to actual organ volumes.
Rajendran JG; Fisher DR; Gopal AK; Durack LD; Press OW; Eary JF
J Nucl Med; 2004 Jun; 45(6):1059-64. PubMed ID: 15181141
[TBL] [Abstract][Full Text] [Related]
15. Differences among Monte Carlo codes in the calculations of voxel S values for radionuclide targeted therapy and analysis of their impact on absorbed dose evaluations.
Pacilio M; Lanconelli N; Lo MS; Betti M; Montani L; Torres AL; Coca PM
Med Phys; 2009 May; 36(5):1543-52. PubMed ID: 19544770
[TBL] [Abstract][Full Text] [Related]
16. Comparison between Targeted Radionuclide Therapy of Bone Metastases Based on β-Emitting and α-Emitting Radionuclides.
Sadremomtaz A; Masoumi M
J Med Imaging Radiat Sci; 2019 Jun; 50(2):272-279. PubMed ID: 31176435
[TBL] [Abstract][Full Text] [Related]
17. Impact on 141Ce, 144Ce, 95Zr, and 90Sr beta emitter dose coefficients of photon and electron SAFs calculated with ICRP/ICRU reference adult voxel computational phantoms.
Li WB; Zankl M; Schlattl H; Petoussi-Henss N; Eckerman KF; Bolch WE; Oeh U; Hoeschen C
Health Phys; 2010 Oct; 99(4):503-10. PubMed ID: 20838091
[TBL] [Abstract][Full Text] [Related]
18. Absorbed fractions for alpha-particles in tissues of trabecular bone: considerations of marrow cellularity within the ICRP reference male.
Watchman CJ; Jokisch DW; Patton PW; Rajon DA; Sgouros G; Bolch WE
J Nucl Med; 2005 Jul; 46(7):1171-85. PubMed ID: 16000287
[TBL] [Abstract][Full Text] [Related]
19. A nephron-based model of the kidneys for macro-to-micro α-particle dosimetry.
Hobbs RF; Song H; Huso DL; Sundel MH; Sgouros G
Phys Med Biol; 2012 Jul; 57(13):4403-24. PubMed ID: 22705986
[TBL] [Abstract][Full Text] [Related]
20. Correlation of red marrow radiation dosimetry with myelotoxicity: empirical factors influencing the radiation-induced myelotoxicity of radiolabeled antibodies, fragments and peptides in pre-clinical and clinical settings.
Behr TM; Béhé M; Sgouros G
Cancer Biother Radiopharm; 2002 Aug; 17(4):445-64. PubMed ID: 12396708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
